Slides and Webcasts from all ESMO Advanced Courses are reserved to ESMO Members and registered participants, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.
ESMO Advanced Course on Role of CDK4/6 Inhibitors in Hormone Receptor Positive HER2 Negative in Breast Cancer 2024: Jeddah
- Start date
- 07 Sep 2024
- End date
- 07 Sep 2024
- Location
- Jeddah, Saudi Arabia
Learning objectives
- Understanding the function and biology of CDK4-6 in breast cancer
- Information and in-depth discussion on the state of the art and emerging therapeutic strategies integrating CDK4-6 inhibition in breast cancer, both in the early and metastatic setting
- Assessing the clinical and genomic features for risk of relapse in early HR+/HER2 negative breast cancer
- Presenting novel data on biomarkers of benefit, mechanisms of resistance and combinatorial therapeutic strategies of CDK4-6 inhibition
- Discussing clinical cancer cases to integrate use of CDK4-6 inhibitors in clinical practice
Co-Chairs
- Giuseppe Curigliano, Italy
- Barbara Pistilli, France
- Meteb Al-Foheidi, Saudi Arabia
Participants
This is a closed course reserved to invited Middle East participants.
What's included?
Participants will benefit from complimentary course registration and accommodation. Travel will be covered as well.
Accreditation
The programme of this event has been accredited with 6 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Health and Safety Policy
It is each participant’s responsibility to check and comply with the latest health and travel regulations to ensure a smooth and safe journey from the Country of origin to the event venue, and back.
During the event, ESMO will apply health and safety protocols according to the latest local authority guidelines and regulations.
In general, ESMO recommends:
- to apply health precautions and measures according to formal guidance and personal medical history
- to stay up to date with the vaccination status
- to perform a Rapid Antigen Test and wear a mask in case of symptoms
Hand sanitisers will be available throughout the venue; the use of mask is at own discretion in the absence of symptoms.
Any changes to the ESMO health and safety protocols will be communicated on this webpage.
Insurance
ESMO bears no responsibility for any untoward events in connection with, before, during and after the course. Participants are strongly advised to take out their own personal and travel coverage.
Venue
Jeddah, Saudi Arabia